Blog

There is growing excitement around a new drug recently approved by the FDA for the treatment of skin cancer. Several studies have provided evidence that the drug may prove effective in treating many other cancers, including advanced mesothelioma. The first drug of its kind, Keytruda (pembrolizumab) works by blocking a cellular pathway caused by PD-1 » Read More

Each year, the Mesothelioma Applied Research Foundation (MARF) holds its annual conference for all those affected by the deadly disease. This year, the International Symposium on Malignant Mesothelioma will take place March 2-4, 2015 at the National Institute of Health and the Hyatt Regency Bethesda in Bethesda, MD. The Mesothelioma Applied Research Foundation partnered with » Read More

Researchers at Brigham and Women’s Hospital in Boston conducted an extensive review of survival rates of mesothelioma patients who have undergone extrapleural pneumonectomy (EPP) surgery. This highly aggressive treatment option involves removal of a lung, the pericardium, and major parts of the diaphragm. Researchers argue that despite growing debate over its effectiveness, the procedure remains a » Read More

In a new study just released, Swiss scientists at the Institute of Diagnostic and Interventional Radiology in Zurich have concluded that a better approach is needed to determine the level of cancer staging in mesothelioma patients. Mesothelioma is a disease that affects the membrane lining of the lungs and abdomen.   It is the most serious » Read More